
-
More good news on ZORAXEL
I've got some good news on ZORAXEL.
I'm not a finance expert, but apparently Rexahn has signed an important deal with Teva. Why is this good news?
a) It shows, once again, that Rexahn is a reliable company. The future of ZORAXEL seems to be in good hands. 
b) The deal will assure more money for the development of ZORAXEL and other new drugs
This what is Chang Ahn, chairman and CEO of Rexahn, said:
“We are pleased that Teva recognises the commercial potential of this discovery. Our agreements with Teva further validate the strength of Rexahn’s drug discovery capabilities and the inherent value of our growing pre-clinical portfolio in oncology. These agreements also provide Rexahn with another secure revenue stream that further supports our push to bring our three very promising phase II compounds, Archexin, Serdaxin and Zoraxel, to market.”
You can read the full article here:
Rexahn, Teva Agree To Close On License Agreement Health News
Last edited by Flavio; 09-19-2009 at 07:16 PM.
Posting Permissions
- You may not post new threads
- You may not post replies
- You may not post attachments
- You may not edit your posts
Forum Rules
All times are GMT. The time now is 05:07 PM.